The data showed that HDAC2 overexpression led to an increase in FOXA3 acetylation in HCC cells only when K218 sites were mutated (Fig. 6f), indicating that K218 was the effective site. The gene discussed is HDAC2; the disease is hepatocellular carcinoma.